Pixantrone as a bridge to CAR-T treatment in high-grade transformation of follicular lymphoma

Eur J Haematol. 2022 Nov;109(5):593-594. doi: 10.1111/ejh.13829. Epub 2022 Jul 26.

Authors

Joseph Morris¹, Maeve O'Reilly², Jeremy Sargent¹, Philip Murphy¹, Siobhan Glavey¹, John Quinn¹

Affiliations

¹ Department of Haematology, Beaumont Hospital, Dublin, Ireland.
² Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.

PMID: 35844204
DOI: 10.1111/ejh.13829

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Isoquinolines / therapeutic use
Lymphoma, Follicular* / diagnosis
Lymphoma, Follicular* / drug therapy
Lymphoma, Non-Hodgkin* / pathology
Receptors, Chimeric Antigen*

Substances

Isoquinolines
Receptors, Chimeric Antigen
pixantrone